Clinical Research, Pharma & Healthcare Financing Archives

Clinical Research, Pharma & Healthcare Financing

CareDx Study: AlloSeq cfDNA Accurately Detects Organ Rejection

Business WireFebruary 21, 2025February 21, 2025

by Business WireFebruary 21, 2025February 21, 202501

AlloSeq cfDNA Consistent with Performance of Proven AlloSure Testing CareDx Brings Innovative Non-Invasive Transplant Monitoring to Patients Internationally with AlloSeq cfDNA CareDx, Inc. (Nasdaq: CDNA)...

Clinical Research, Pharma & Healthcare Financing

Variational AI Secures $5.5M to Launch AI for Drug Discovery

Business WireFebruary 21, 2025February 21, 2025

by Business WireFebruary 21, 2025February 21, 202501

New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies Variational AI, the company behind Enki™, an advanced foundation model for...

Clinical Research, Pharma & Healthcare Financing

Alzamend Neuro Completes Novel Head Coil for Phase II Trials

Business WireFebruary 20, 2025February 21, 2025

by Business WireFebruary 20, 2025February 21, 202504

Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy, Alzheimer’s disease,...

Clinical Research, Pharma & Healthcare Financing

Thetis Pharmaceuticals Unveils TP-317 Data at ECCO 2025

Business WireFebruary 20, 2025February 21, 2025

by Business WireFebruary 20, 2025February 21, 202503

Phase 1a Clinical Results Demonstrate a Favorable Safety Profile and BLT1 Engagement In Healthy Volunteers Preclinical Data Highlight TP-317’s Anti-Inflammatory, Epithelial Barrier-Protective Effects Thetis Pharmaceuticals...

Clinical Research, Pharma & Healthcare Financing

Kiromic BioPharma Reports 10-Month Progression-Free Survival

Business WireFebruary 19, 2025February 20, 2025

by Business WireFebruary 19, 2025February 20, 202508

Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports continued favorable efficacy results from the 10-month follow-up visit for the fourth patient enrolled in its...

Clinical Research, Pharma & Healthcare Financing

Novotech Partners with Wonju Severance for Clinical Research

Business WireFebruary 19, 2025February 20, 2025

by Business WireFebruary 19, 2025February 20, 202507

Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced...

Clinical Research, Pharma & Healthcare Financing

Celltrion Expands Biosimilar Portfolio with EU Approval

Business WireFebruary 19, 2025February 20, 2025

by Business WireFebruary 19, 2025February 20, 202506

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to treat multiple...

Clinical Research, Pharma & Healthcare Financing

NationsBenefits® Expands Retail Network with Walgreens

Business WireFebruary 18, 2025February 19, 2025

by Business WireFebruary 18, 2025February 19, 202509

NationsBenefits®, the leading healthcare fintech, supplemental benefits, and outcomes platform, announced their latest retail integration with Walgreens, one of the nation’s leading integrated healthcare and pharmacy...

Clinical Research, Pharma & Healthcare Financing

European Commission Approves CSL & Arcturus’ KOSTAIVE®

Business WireFebruary 17, 2025February 18, 2025

by Business WireFebruary 17, 2025February 18, 202507

KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to 12 months post-vaccination compared to conventional mRNA COVID-19...

Clinical Research, Pharma & Healthcare Financing

ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research

Business WireFebruary 17, 2025February 18, 2025

by Business WireFebruary 17, 2025February 18, 202509

Study showing that Decipher GRID-derived PORTOS signature predicts benefit from dose-escalated radiation therapy also published in Annals of Oncology Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics...

Category : Clinical Research, Pharma & Healthcare Financing

CareDx Study: AlloSeq cfDNA Accurately Detects Organ Rejection

Variational AI Secures $5.5M to Launch AI for Drug Discovery

Alzamend Neuro Completes Novel Head Coil for Phase II Trials

Thetis Pharmaceuticals Unveils TP-317 Data at ECCO 2025

Kiromic BioPharma Reports 10-Month Progression-Free Survival

Novotech Partners with Wonju Severance for Clinical Research

Celltrion Expands Biosimilar Portfolio with EU Approval

NationsBenefits® Expands Retail Network with Walgreens

European Commission Approves CSL & Arcturus’ KOSTAIVE®

ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research

The Leadership Development Playbook for Gen Z and...

Harnessing 5G and IoT to Drive CRM and...

Embracing Competency-Based Learning for Future-Ready Workforces

Top Four Innovative Proptech Trends to Look for...

Zyxel Offers Partners Risk-Free Trial of Nebula for...

Quick Links

Stay up to date